| Application number | Title of the application | Filing Date | Status |
|---|
| 08/592378 | INTRACELLULAR IMMUNIZATION | Jan 29, 1996 | Abandoned |
Array
(
[id] => 3775322
[patent_doc_number] => 05808012
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Protein-enriched thermoplastics'
[patent_app_type] => 1
[patent_app_number] => 8/587333
[patent_app_country] => US
[patent_app_date] => 1996-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20571
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/808/05808012.pdf
[firstpage_image] =>[orig_patent_app_number] => 587333
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/587333 | Protein-enriched thermoplastics | Jan 15, 1996 | Issued |
Array
(
[id] => 3803106
[patent_doc_number] => 05830690
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Process for producing polypeptides'
[patent_app_type] => 1
[patent_app_number] => 8/578158
[patent_app_country] => US
[patent_app_date] => 1995-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9062
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830690.pdf
[firstpage_image] =>[orig_patent_app_number] => 578158
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/578158 | Process for producing polypeptides | Dec 28, 1995 | Issued |
Array
(
[id] => 3986558
[patent_doc_number] => 05910434
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-08
[patent_title] => 'Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant'
[patent_app_type] => 1
[patent_app_number] => 8/572959
[patent_app_country] => US
[patent_app_date] => 1995-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 25
[patent_no_of_words] => 19567
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/910/05910434.pdf
[firstpage_image] =>[orig_patent_app_number] => 572959
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/572959 | Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant | Dec 14, 1995 | Issued |
Array
(
[id] => 3866408
[patent_doc_number] => 05837512
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'HIV-1 vectors'
[patent_app_type] => 1
[patent_app_number] => 8/574586
[patent_app_country] => US
[patent_app_date] => 1995-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 15
[patent_no_of_words] => 7621
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837512.pdf
[firstpage_image] =>[orig_patent_app_number] => 574586
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/574586 | HIV-1 vectors | Dec 13, 1995 | Issued |
Array
(
[id] => 4061703
[patent_doc_number] => 05866385
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'Lactic acid bacterial suppressor mutants and their use as selective markers and as means of containment in lactic acid bacteria'
[patent_app_type] => 1
[patent_app_number] => 8/535092
[patent_app_country] => US
[patent_app_date] => 1995-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23231
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866385.pdf
[firstpage_image] =>[orig_patent_app_number] => 535092
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/535092 | Lactic acid bacterial suppressor mutants and their use as selective markers and as means of containment in lactic acid bacteria | Dec 4, 1995 | Issued |
Array
(
[id] => 3733377
[patent_doc_number] => 05698389
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-16
[patent_title] => 'Transcriptional promoter of the murine obesity gene'
[patent_app_type] => 1
[patent_app_number] => 8/558545
[patent_app_country] => US
[patent_app_date] => 1995-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 5357
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/698/05698389.pdf
[firstpage_image] =>[orig_patent_app_number] => 558545
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/558545 | Transcriptional promoter of the murine obesity gene | Nov 15, 1995 | Issued |
Array
(
[id] => 4030312
[patent_doc_number] => 05942254
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-24
[patent_title] => 'Phosphorylated recombinant human .beta.-casein expressed in a bacterial system'
[patent_app_type] => 1
[patent_app_number] => 8/554137
[patent_app_country] => US
[patent_app_date] => 1995-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9982
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/942/05942254.pdf
[firstpage_image] =>[orig_patent_app_number] => 554137
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/554137 | Phosphorylated recombinant human .beta.-casein expressed in a bacterial system | Nov 5, 1995 | Issued |
Array
(
[id] => 3812129
[patent_doc_number] => 05710044
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-20
[patent_title] => 'Plasmid for expressing phosphorylated recombinant proteins in a bacterial system'
[patent_app_type] => 1
[patent_app_number] => 8/554642
[patent_app_country] => US
[patent_app_date] => 1995-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9903
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/710/05710044.pdf
[firstpage_image] =>[orig_patent_app_number] => 554642
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/554642 | Plasmid for expressing phosphorylated recombinant proteins in a bacterial system | Nov 5, 1995 | Issued |
| 08/558588 | MODULATORS OF OBETA GENE AND SCREENING METHODS THEREFOR | Oct 29, 1995 | Abandoned |
Array
(
[id] => 3868485
[patent_doc_number] => 05763217
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-09
[patent_title] => 'Method of using, process of preparing and composition comprising recombinant herpesvirus vectors'
[patent_app_type] => 1
[patent_app_number] => 8/540692
[patent_app_country] => US
[patent_app_date] => 1995-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 25
[patent_no_of_words] => 18083
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/763/05763217.pdf
[firstpage_image] =>[orig_patent_app_number] => 540692
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/540692 | Method of using, process of preparing and composition comprising recombinant herpesvirus vectors | Oct 10, 1995 | Issued |
Array
(
[id] => 3738986
[patent_doc_number] => 05786145
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-28
[patent_title] => 'Oligonucleotide competitors for binding of HIV RRE to REV protein and assays for screening inhibitors of this binding'
[patent_app_type] => 1
[patent_app_number] => 8/540448
[patent_app_country] => US
[patent_app_date] => 1995-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 32
[patent_no_of_words] => 14208
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/786/05786145.pdf
[firstpage_image] =>[orig_patent_app_number] => 540448
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/540448 | Oligonucleotide competitors for binding of HIV RRE to REV protein and assays for screening inhibitors of this binding | Oct 9, 1995 | Issued |
Array
(
[id] => 3780412
[patent_doc_number] => 05821046
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'RNA oligonucleotides that bind HIV tat protein'
[patent_app_type] => 1
[patent_app_number] => 8/541950
[patent_app_country] => US
[patent_app_date] => 1995-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 60
[patent_no_of_words] => 19452
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821046.pdf
[firstpage_image] =>[orig_patent_app_number] => 541950
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/541950 | RNA oligonucleotides that bind HIV tat protein | Oct 9, 1995 | Issued |
Array
(
[id] => 3861772
[patent_doc_number] => 05795872
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-18
[patent_title] => 'DNA construct for immunization'
[patent_app_type] => 1
[patent_app_number] => 8/530529
[patent_app_country] => US
[patent_app_date] => 1995-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6212
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/795/05795872.pdf
[firstpage_image] =>[orig_patent_app_number] => 530529
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/530529 | DNA construct for immunization | Sep 18, 1995 | Issued |
| 08/495684 | COMPOSITIONS AND METHODS FOR DELIVERY OF GENETIC MATERIAL | Aug 27, 1995 | Abandoned |
Array
(
[id] => 3725826
[patent_doc_number] => 05702902
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-30
[patent_title] => 'Methods for the diagnosis of body weight disorders including obesity'
[patent_app_type] => 1
[patent_app_number] => 8/518878
[patent_app_country] => US
[patent_app_date] => 1995-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 26
[patent_no_of_words] => 35054
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/702/05702902.pdf
[firstpage_image] =>[orig_patent_app_number] => 518878
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/518878 | Methods for the diagnosis of body weight disorders including obesity | Aug 22, 1995 | Issued |
Array
(
[id] => 3883861
[patent_doc_number] => 05776771
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'Kanamycin resistance gene derived from microorganisms of the genus rhodococcus'
[patent_app_type] => 1
[patent_app_number] => 8/510878
[patent_app_country] => US
[patent_app_date] => 1995-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1449
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/776/05776771.pdf
[firstpage_image] =>[orig_patent_app_number] => 510878
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/510878 | Kanamycin resistance gene derived from microorganisms of the genus rhodococcus | Aug 2, 1995 | Issued |
| 08/510584 | MODULATORS OF OB GENE AND SCREENING METHODS THEREFOR | Aug 1, 1995 | Abandoned |
Array
(
[id] => 3886658
[patent_doc_number] => 05834188
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-10
[patent_title] => 'Methods and compositions for identifying morphogen analogs'
[patent_app_type] => 1
[patent_app_number] => 8/507598
[patent_app_country] => US
[patent_app_date] => 1995-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15217
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/834/05834188.pdf
[firstpage_image] =>[orig_patent_app_number] => 507598
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/507598 | Methods and compositions for identifying morphogen analogs | Jul 25, 1995 | Issued |
Array
(
[id] => 3963914
[patent_doc_number] => 05885808
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-23
[patent_title] => 'Adenovirus with modified binding moiety specific for the target cells'
[patent_app_type] => 1
[patent_app_number] => 8/428257
[patent_app_country] => US
[patent_app_date] => 1995-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 30
[patent_no_of_words] => 15251
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/885/05885808.pdf
[firstpage_image] =>[orig_patent_app_number] => 428257
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/428257 | Adenovirus with modified binding moiety specific for the target cells | Jul 4, 1995 | Issued |